News related to
Gold

Agency leader Bryan Phang is the sole COE (Diamond Agency) winner to achieve four consecutive award wins; Prudential’s solid showing underpinned by its strong knowledge sharing and mentorship culture

SINGAPORE – Media OutReach Newswire – 7 July 2026 – Prudential Singapore (“Prudential”) achieved the strongest showing globally in the 2026 Million Dollar Round Table (MDRT) Culture of Excellence (COE) Awards, with 29 agency leaders recognised out of 68 winners worldwide. This was up from 13 winners in 2025, reflecting the strong progress made by Prudential’s agency force. Accounting for more than two in five award recipients this year, Prudential had the highest number of MDRT COE Award winners globally.

The MDRT COE Award recognises agency leaders who deliver strong outcomes across six dimensions of agency management¹: production, retention, recruitment, persistency, whole person, and MDRT or MDRT Academy membership.

Mr Rom Lee, Chief Agency Officer, Prudential Singapore, said: “Having 29 agency leaders recognised on the global MDRT Culture of Excellence Awards, up from 13 last year, is a strong affirmation of the standards our leaders set for themselves and their teams. Beyond individual achievement, it reflects a culture grounded on discipline, a strong MDRT sharing culture and a deep commitment to helping customers make confident financial decisions.

“We have worked to create an environment where financial representatives can grow their careers, perform at a high level and be recognised for their achievements. As customer needs continue to evolve, this culture of excellence will remain central to how we develop a trusted, future-ready agency.”

MDRT COE Award winner Mr Bryan Phang, Financial Services Director, Prudential Singapore, is the only Diamond Agency recipient globally to achieve this distinction for a fourth consecutive year. This year, the agency went a step further by achieving all six criteria of the Award. Said Mr Phang: “Earning this recognition for a fourth consecutive year is meaningful. The best teams make each other better. For us, it’s about developing people, building leaders and creating a culture that can sustain success over time. We hope this recognition raises the bar for what strong agency culture and high standards can achieve.”

New MDRT COE Award winner, Ms Chiam Shu Yi, Wealth Director, Prudential Financial Advisers Singapore, Platinum Agency, is recognised for developing the careers of young and mid-career financial representatives. Said Ms Chiam: “Success is never built alone. The greatest fulfilment in leadership is investing in people, helping them discover hidden confidence, and reach milestones which they thought were out of reach. By supporting others, you empower them to grow, succeed, and build lives and careers they are proud of.”

Agency leaders awarded the MDRT Culture of Excellence Award include:

Prudential’s agency force has continued to deliver strong results and a consistently growing number of qualifiers. In 2026, it had 1,425 MDRT qualifiers, including 186 Court of The Table (TOT) and 73 Top of the Table (TOT) qualifiers, as well as 29 MDRT COE Award winners.

Prudential continues to invest in capability building across its agency force through training and professional development pathways. These include the Financial Consultant Induction Programme (FCIP) for new joiners, which leads to an Institute of Banking and Finance Qualified (Level 1) certification, as well as leadership development tracks such as the Chartered Insurance Agency Manager designation.

The company also equips financial representatives to serve affluent and high-net-worth customers through its in-house High Net Worth Skill Up Series and external programmes including the Certified Affluent Wealth Adviser and Advanced Affluent Wealth Adviser courses by the Wealth Management Institute. In 2024, Prudential also enhanced its Management Associate Programme (MAP) to support fresh graduates and young professionals pursuing a career as financial representatives².

Prudential has 5,400 financial representatives with its tied agency and financial advisory arm, Prudential Financial Advisers Singapore, as of 31 December 2025.

1 For more information on criteria for MDRT Culture of Excellence Awards, please visit: https://www.mdrtcenter.org/culture-of-excellence-awards
2 For more information about the enhanced Management Associate Programme, visit: https://www.prudential.com.sg/about/newsroom/press-release/2024/prudential-ramps-up-hiring

Hashtag: #Prudential #PrudentialSingapore #MDRTCOE #MDRTCultureofExcellenceAward

https://www.prudential.com.sg/
https://sg.linkedin.com/company/prudential-assurance-company-singapore
https://www.facebook.com/PrudentialSingapore/
https://www.instagram.com/prudentialsingapore/

The issuer is solely responsible for the content of this announcement.

About Prudential Assurance Company Singapore (Pte) Ltd (Prudential Singapore)

Prudential Assurance Company Singapore (Pte) Ltd is one of the top life and health insurance companies in Singapore, serving the financial and protection needs of the country’s citizens for 95 years. As at 31 December 2025, it has S$66.3 billion funds under management. The company has an AA Financial Strength Rating from leading credit rating agency Standard & Poor’s and delivers a suite of well-rounded product offerings in Protection, Savings and Investment through multiple distribution channels including a network of 5,400 financial representatives.

About MDRT Center for Field Leadership

The MDRT Center for Field Leadership was created exclusively for financial services field and home office leaders. As a separate, individual membership association with innovative leadership development strategies, the MDRT Center provides its members with exceptional value and leadership growth opportunities. MDRT Center membership allows increased engagement within the MDRT community while allowing leaders to develop a culture of excellence within their respective organizations. To learn more visit mdrtcenter.org.

By K Raveendran The alleged theft of donations from the Ayodhya Ram Temple has pushed a long-simmering question into the national foreground: who should guard the wealth of religious institutions when faith, money and power converge without adequate public accountability? The issue is not confined to Ayodhya, nor to Hindu institutions. Across denominations, religious endowments, […]

The article Faith Assets Need Secular Oversight As Temple Fraud Exposes Governance Vacuum appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

The inaugural India–Mali Forum for the Promotion of Exports was held in Bamako under the theme “Reinforcing Trade and Strategic Partnerships”, bringing together senior officials, export agencies and about 30 business leaders from India. The two-day initiative marks an attempt to move commercial engagement beyond commodity flows and towards sector-specific projects in cotton, mining, energy, pharmaceuticals, agro-processing, health and education.

The forum was jointly organised by Mali’s Ministry of Industry and Trade, the Embassy of India in Bamako and the Malian Agency for the Promotion of Exports. It was presided over by Mali’s Transition Government Prime Minister, Major General Abdoulaye Maïga, with the delegation from India led by Amit Kumar, Joint Secretary for FT-Africa in the Department of Commerce. Dr N. Nandakumar, Ambassador of India to Mali, represented the mission through the proceedings.

Bilateral trade crossed $326.61 million in 2025–26, a 55 per cent increase over the previous financial year. Mali’s exports to India include raw cotton, finished leather, cashew, lead, gum arabic and sesame. India’s exports to Mali include pharmaceuticals, cotton fabrics, two-wheelers, three-wheelers and bicycles. Officials see the current trade base as narrow but expandable, particularly because Mali’s global exports stand at about $4 billion and its untapped export potential in the market of India is estimated at nearly $3.96 billion.

The Duty-Free Tariff Preference Scheme has been a central driver of trade growth, offering least developed countries preferential access to the market of India. For Mali, the scheme provides a policy opening at a time when Bamako is seeking to diversify export destinations and reduce dependence on raw commodity shipments. For New Delhi, the forum fits a wider push to deepen commercial links with Africa through trade facilitation, capacity building and private-sector participation.

Business-to-business, business-to-government and government-to-government meetings formed the operational core of the forum. Exhibition stands featured products from both countries, including tractors and vehicles manufactured by Sonalika, Mahindra and Tata Motors. The format was designed to connect firms with regulators, identify bankable projects and address procedural bottlenecks that often slow trade between developing markets.

Mali presented ready-made business plans to potential investors and placed emphasis on agro-industry, shea processing, mining-linked services, renewable energy and social infrastructure. The country is seeking more value addition in cotton and agricultural commodities rather than relying mainly on exports of raw or semi-processed products. Cotton remains a significant sector for Mali, while shea, sesame, cashew and gum arabic offer scope for processing, branding and direct export partnerships.

Pharmaceuticals emerged as another key area. Mali sought quicker registration of approved products from India, a move that could expand access to affordable medicines and medical supplies. Health and education infrastructure were also discussed as areas where companies and institutions could provide services, equipment and training support.

The mining dimension is more complex. Mali is one of Africa’s leading gold producers and is working to tighten oversight of its precious metals trade after identifying large gaps between declared exports and import data reported by partner countries. A new state entity has been created to centralise and regulate precious-substances flows, reflecting Bamako’s effort to capture more value from gold and reduce informal trade. Industrial mines export about 60 tonnes of gold annually, while artisanal mining employs nearly 2 million people across hundreds of sites.

Security remains a central concern for investors. Mali has faced instability and militant violence, and economic assets have been among the risks flagged by foreign governments and companies. Earlier this year, security concerns stalled participation by government-backed firms from India in a Russian-backed lithium exploration project in Mali. That episode underlined the challenge of matching mineral ambitions with investor confidence.

Spacebiz in Hong Kong – a golden opportunity for Professional Services and STEM

HONG KONG SAR – Media OutReach Newswire – 29 June 2026 – Space Economy Association (Hong Kong) Ltd, or “SEA”, officially formed in the midst of the space economy boom. It is an independent membership-based non-government organisation dedicated to connecting and facilitating space-related industries, businesses, investors, educators, experts, and governments worldwide in their pursuit for businesses and technology in commercial space. SEA helps establish Hong Kong as a super-connector hub in the international space ecosystem by capitalising on our professional services, led by finance.

The new renaissance is in the space economy. The US$630 billion global space economy is set to triple to US$1.8 trillion^[1] by 2035. With launch costs dropping 10-fold in the last 20 years, private and public sectors will soar with all humanity set to benefit. Space economy is ubiquitous and creating value beyond rocketry and satellites, everyone will flourish as the space economy grows 9% per annum. China is the world’s second largest player in space, highlighting it as one of the four emerging strategic industries in its 15th National Five-Year Plan. Its commercial space sector has already launched 81 rockets and 336 satellites into orbit, with over 100 space start-ups and companies raising around US$6.5 billion. Hong Kong, as a key international financial centre practicing Common Law with international arbitration system and robust insurance, data and intellectual property protection capabilities, uniquely stands to serve China and other countries to pursue capital, business, technology and talent in commercial space.

“From Hong Kong’s perspective, the NewSpace economy is not simply about rockets or satellites; it is about the commercial possibilities they create for our professional services community. As the nation advances its aerospace ambitions, Hong Kong’s strengths in finance, insurance, law and related fields equip the city to support activities ranging from project financing and initial public offerings to risk management and crossborder transactions. Our bankers, insurers, accountants and lawyers are ideally positioned to help turn space initiatives into viable enterprises — and to participate directly in the value they generate.” said the Honourable Bernard Charnwut Chan, GBM, GBS, JP. Patron of SEA.

“Hong Kong’s top-class professional services would facilitate the processes from research and innovation to startup, scale-up and successful space business. Besides a hub for IPOs, Hong Kong offers funding from seed and angel, to private equity, venture capital, mergers and acquisitions, in debt, equity, and lease financing. This space economy would contribute plentiful job and business opportunities to become a key pillar of Hong Kong in terms of economy and quality opportunities for our young generation,” said Professor Richard Leung, Chairman of SEA. “SEA’s global network of partners grows beyond Asia, North America and Europe to include the UNOOSA ecosystem. SEA is a platform that empowers astropreneurs to launch towards humanity’s collective space dream.”

SEA is governed by a Board of 19 members and supported by nine committees. SEA is also strongly supported by a Patron and five Fellows who share the vision to position Hong Kong as a leading hub in the international space economy. The Honourable Bernard Charnwut Chan, GBM, GBS, JP is SEA’s Patron with Fellows Dr. Anthony Neoh, KC, SC, JP, Chairman, Asian Academy of International Law, Prof. Jin-Guang Teng, BBS, JP, President, The Hong Kong Polytechnic University, Mr. Jimmy Tsang, General Manager, Goldlion, Mr. Roger Tong, Chief Executive Officer, AsiaSat, and Prof. Gregg Li, Adjunct Professor at the Laboratory for Space Research, The University of Hong Kong.

As this new economy requires education first, SEA began as the Orion Astropreneur Space Academy or OASA, with an aim to herald and teach this new economy. OASA was formed in 2020 to accelerate the awakening of young executives and professionals through action-learning and Artificial Intelligence, preparing them for the NewSpace economy. OASA has made important strides in advancing NewSpace awareness, talent development, and ecosystem building. It has engaged more than 200,000 visits, worked with over 50 partner organisations, and organised more than 60 courses and activities. As OASA evolves into SEA, the OASA remains the brand for school development programmes and youth-focused education.

SEA membership is a community of 100 co-founders, 150+ active members, 250+ student members, and 40+ industry partners shaping the future of NewSpace in the Greater Bay Area. Members connect with leading innovators, world-class institutions, global mentors, and industry leaders at the forefront of the commercial space. SEA provides a trusted platform for dialogue, collaboration, and engagement through events and direct connections. Members can access closed-door industry dialogues, international delegations, early opportunities for partnerships, and connect with an internationally respected network.

SEA’s membership framework has full, associate, and fellow membership options to serve this diverse community. All members benefit from preferential event rates, networking opportunities, curated market intelligence, professional development, and selected business support services. Full Members enjoy governance rights at general meetings, while higher-tier and charter members receive additional recognition and priority access.

Hashtag: #SpaceEconomyAssociation #SEA

The issuer is solely responsible for the content of this announcement.

About Space Economy Association (Hong Kong) Ltd

Space Economy Association (Hong Kong) Ltd (SEA) is an independent, membership-based NGO dedicated to connecting and facilitating space-related industries, businesses, investors, educators, experts, and governments worldwide in their pursuit of commercial space business and technology. SEA aims to help establish Hong Kong as a super-connector hub within the international space ecosystem by capitalising on its strengths in professional services, led by finance. SEA’s membership comprises a community of 100 co-founders, over 150 active members, more than 250 student members, and 40+ industry partners, all contributing to shaping the future of NewSpace in the Greater Bay Area. Members benefit from access to closed-door industry dialogues, international delegations, early partnership opportunities, and connections with a respected global network, including the UNOOSA ecosystem. SEA’s growing global network of partners spans Asia, North America, and Europe.

The West Synchrony™ Prefillable Syringe (PFS) System offers strategic infrastructure to support Chinese biotech innovators to expand their global footprint in biologics and vaccines.

SHANGHAI, CHINA – Media OutReach Newswire – 16 June 2026 – West Pharmaceutical Services, Inc. (NYSE: WST), a long-standing partner to China’s pharmaceutical industry, today announced the availability of its West Synchrony™ prefillable syringe (PFS) system to drug developers at CPHI & PMEC China 2026, taking place June 16-18, 2026. This innovative platform uniquely integrates the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier and emphasizes the company’s commitment to supporting the development of China’s biopharmaceutical sector in alignment with the country’s 15th Five-Year Plan. By strengthening the innovation ecosystem and accelerating development and time to market, the company supports China’s biopharmaceutical companies in achieving biotechnology breakthroughs and reaching global milestones.

Enabling China’s Next Phase of Global Biopharmaceutical Growth

To support Chinese biopharmaceutical companies in their ambitions, West has now made the West Synchrony™ PFS system available in the country.

This gives Chinese innovators the infrastructure needed to compete on quality, safety, and regulatory compliance across international markets, with greater confidence and efficiency.

“Chinese biopharmaceutical companies today have established themselves as serious global innovators, with significant opportunities to sustain momentum through high‑quality innovation,” said Maha Guruswamy, Vice President & Managing Director, Commercial, Asia Pacific. “The challenge is that a traditional, individual-component system introduces significant technical and regulatory complexities. West Synchrony addresses these by providing a fully verified and integrated containment and delivery system from a single source, allowing our partners to accelerate development and focus on delivering therapies to patients.”

Deepening A Long-Term Partnership with China’s Pharmaceutical Ecosystem

The introduction of the West Synchrony™ PFS system reflects the company’s decades-long commitment to supporting pharmaceutical innovation. This investment extends beyond product offerings to include technical expertise, regulatory support, and a single source of accountability that serve both domestic Chinese companies and multinational partners operating in China.

“As China’s biopharmaceutical companies continue to strengthen their capabilities and expand their presence globally, West is committed to partnering with them at every stage of their growth journey,” said Philip Wang, Senior Director, Commercial, China. “We aim to enable them to achieve their global ambitions, and the West Synchrony™ PFS system is one example from our portfolio of high‑quality, innovative solutions that provide customers with the same trusted infrastructure relied upon by leading multinational pharmaceutical companies worldwide.”

Join West at CPHI & PMEC China 2026

The West Synchrony™ PFS system will be showcased at CPHI & PMEC China 2026, where an expert from West will present on the role of integrated delivery systems in supporting China’s next phase of biopharmaceutical innovation and its global ambitions for expansion. Trade media and industry stakeholders interested in learning more about the technology and its application in biologics are invited to visit the West booth during the exhibition. The details of the presentation are as follows:

Presentation: “Stop Piecing It Together—Get an Integrated Verified Prefillable Syringe System from One Source”

• Date & Time: June 17, 14:10-14:40

• Location: Shanghai New International Expo Center

• Speaker: Lynn Yao, Senior Manager, TCS, AP

The West Synchrony™ PFS System is now available to bio and pharmaceutical companies in China. Visit West at Booth N5D18 to learn more, or find out more information via the website here.

Forward-Looking Statements

Certain forward-looking statements are included in this press release. They use words and phrases such as “achieving biotechnology breakthroughs,” “reaching global milestones,” “accelerate development,” and other similar terminology. These statements include, but are not limited to, statements regarding the anticipated benefits of the West Synchrony™ prefillable syringe system in China, the expected growth of China’s bio-health and pharmaceutical industries, and West’s ability to support customers’ development and commercialization efforts. These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this release.

Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Factors that could cause actual results to differ materially include, but are not limited to, changes in market conditions, regulatory requirements, global economic and geopolitical conditions, customer demand, supply chain constraints, competitive developments, technological changes, and other risks. These important factors are not all inclusive. For a description of certain additional factors that could cause West’s future results to differ from those expressed in any such forward-looking statements, see Item 1A, entitled “Risk Factors,” in West’s Annual Report on Form 10-K for the year that ended on December 31, 2025. Except as required by law or regulation, West undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise.

Hashtag: #WestPharmaceuticalServices

The issuer is solely responsible for the content of this announcement.

About West Pharmaceutical Services, Inc.

Headquartered in Exton, Pennsylvania, USA, West in its fiscal year 2025 generated USD 3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor’s 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries in the United States and other jurisdictions, unless otherwise noted.